A recent meta-analysis of randomized controlled trials (RCTs), including AMPLITUDE-O, examining six GLP-1 receptor agonists (lixisenatide, liraglutide, subcutaneous semaglutide, exenatide, dulaglutide, and efpeglenatide) reported a 21% reduction in a composite kidney outcome (macroalbuminuria, doubling of serum creatinine or 40% eGFR decline, RRT, or death from kidney disease), corresponding to a number needed to treat of 47 [73]
Following guidance on what to eat on tirzepatide helps you balance macronutrients with hydration needs
10.1093/protein/gzn028 20
It is difficult to explain these results in any other way than that Ero1 directly oxidizes PDI, which in turn oxidizes substrates
Users taking these medications for pain management may find BPC-157 helps offset the healing impairment these drugs can cause
AEs leading to discontinuation of therapy occurred in 10% and 8% for the semaglutide 1 mg and 0.5 mg groups and 7% and 5% for the dulaglutide 1.5 mg and 0.75 mg groups